Literature DB >> 1337906

Adrenocorticotropic hormone and beta-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases.

A Colao1, B Merola, R Spaziante, G La Tessa, F Boudouresque, C Oliver, G Lombardi.   

Abstract

Aim of the present study was the evaluation of ACTH and beta-endorphin-like-immunoreactivity (beta-ELI) in the inferior petrosal sinuses (IPS's) and in the peripheral blood of patients with Cushing's disease (Group 1), with GH- or PRL-secreting adenomas or nontumoral hyperprolactinemia (Group 2). These patients had undergone selective and bilateral simultaneous IPS sampling for diagnostic purposes or for neurosurgical indications. In the patients of Group 1, ACTH and beta-ELI levels were higher in the IPS ipsilateral than in the contralateral to the adenoma and in the periphery (p < 0.001). In the patients of Group 2 ACTH and beta-ELI levels were higher in the IPS's than in the peripheral blood (p < 0.001) and, in the 9 patients with GH- or PRL-secreting adenomas, they were higher in the IPS ipsilateral than in the contralateral to the adenoma and in the periphery (p < 0.05). A significant correlation exists between ACTH and beta-ELI in the periphery (p < 0.01; r = 0.72), in the IPS ipsilateral (p < 0.05; r = 0.54) and contralateral (p < 0.01; r = 0.66) to the adenoma in Group 1, but not in Group 2. In conclusion, higher beta-ELI levels were detected in the IPS's than in the peripheral blood not only in patients with Cushing's disease but also in those with other pituitary diseases not involving ACTH secretion. The absence of correlation between ACTH and beta-ELI in patients not bearing Cushing's disease suggests that in these conditions corticotrophs release ACTH and beta-endorphin in an independent manner.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337906     DOI: 10.1007/bf03348809

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

1.  The use of intercavernous sinuses phlebography in the diagnosis of ACTH-secreting microadenomas.

Authors:  B Merola; G Lombardi; G Lupoli; G De Chiara; A M Colao; L Finelli; L A Marzano; V Iaccarino; L Zarrilli
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

2.  Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling.

Authors:  E H Oldfield; G P Chrousos; H M Schulte; M Schaaf; P E McKeever; A G Krudy; G B Cutler; D L Loriaux; J L Doppman
Journal:  N Engl J Med       Date:  1985-01-10       Impact factor: 91.245

Review 3.  Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues.

Authors:  A I Smith; J W Funder
Journal:  Endocr Rev       Date:  1988-02       Impact factor: 19.871

4.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

5.  Diurnal rhythms of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in normal subjects and in patients with Addison's disease and Cushing's disease.

Authors:  K Sekiya; H Nawata; K Kato; T Motomatsu; H Ibayashi
Journal:  Endocrinol Jpn       Date:  1986-10

6.  A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease.

Authors:  B Allolio; R W Günther; G Benker; D Reinwein; W Winkelmann; H M Schulte
Journal:  J Clin Endocrinol Metab       Date:  1990-11       Impact factor: 5.958

7.  Multiple pituitary hormone gradients from inferior petrosal sinus sampling in Cushing's disease.

Authors:  P A Crock; R G Pestell; A J Calenti; E J Gilford; J K Henderson; J D Best; F P Alford
Journal:  Acta Endocrinol (Copenh)       Date:  1988-09

8.  Evidence for an ultradian secretion of adrenocorticotropin, beta-endorphin and alpha-melanocyte-stimulating hormone by the ovine anterior and intermediate pituitary.

Authors:  D Engler; T Pham; M J Fullerton; I J Clarke; J W Funder
Journal:  Neuroendocrinology       Date:  1989-04       Impact factor: 4.914

9.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

10.  Selective venous sampling for ACTH in Cushing's syndrome: differentiation between Cushing disease and the ectopic ACTH syndrome.

Authors:  J W Findling; D C Aron; J B Tyrrell; J H Shinsako; P A Fitzgerald; D Norman; C B Wilson; P H Forsham
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391

View more
  4 in total

1.  Obesity education in medical schools, residencies, and fellowships throughout the world: a systematic review.

Authors:  Marissa R Mastrocola; Sebastian S Roque; Lauren V Benning; Fatima Cody Stanford
Journal:  Int J Obes (Lond)       Date:  2019-09-24       Impact factor: 5.095

2.  Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration.

Authors:  A Colao; R Pivonello; D Ferone; G La Tessa; A Faggiano; G Facciolli; C Di Somma; B Merola; G Lombardi
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

3.  Inferior petrosal sinus ACTH and prolactin responses to CRH in ACTH-dependent Cushing's syndrome: a single centre experience from the United Kingdom.

Authors:  Christina Daousi; Thomas Nixon; Mohsen Javadpour; Katharine Hayden; Ian A MacFarlane
Journal:  Pituitary       Date:  2010-06       Impact factor: 4.107

Review 4.  Bilateral inferior petrosal sinus sampling.

Authors:  Benedetta Zampetti; Erika Grossrubatscher; Paolo Dalino Ciaramella; Edoardo Boccardi; Paola Loli
Journal:  Endocr Connect       Date:  2016-06-27       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.